Stockreport

Novavax Advances Development of Novel COVID-19 Vaccine

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF Vaccine candidate derived from coronavirus spike (S) proteinMatrix-M™ adjuvant expected to boost immune responsesPhase 1 clinical trial planned for late spring GAITHERS [Read more]